Anna Turkova

2.3k total citations
47 papers, 649 citations indexed

About

Anna Turkova is a scholar working on Infectious Diseases, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Anna Turkova has authored 47 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 22 papers in Epidemiology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Anna Turkova's work include HIV/AIDS drug development and treatment (17 papers), HIV/AIDS Research and Interventions (15 papers) and Pneumocystis jirovecii pneumonia detection and treatment (14 papers). Anna Turkova is often cited by papers focused on HIV/AIDS drug development and treatment (17 papers), HIV/AIDS Research and Interventions (15 papers) and Pneumocystis jirovecii pneumonia detection and treatment (14 papers). Anna Turkova collaborates with scholars based in United Kingdom, South Africa and Uganda. Anna Turkova's co-authors include Diana M. Gibb, Claire Thorne, Andrew McArdle, Aubrey J. Cunnington, Elena Chiappini, Luisa Galli, Elisabetta Venturini, Maurizio de Martino, Mary‐Ann Davies and Mike Sharland and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Hepatology.

In The Last Decade

Anna Turkova

43 papers receiving 638 citations

Peers

Countries citing papers authored by Anna Turkova

Since Specialization

Citations

This map shows the geographic impact of Anna Turkova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Turkova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Turkova more than expected).

Fields of papers citing papers by Anna Turkova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Turkova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Turkova. The network helps show where Anna Turkova may publish in the future.

Co-authorship network of co-authors of Anna Turkova

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Turkova. A scholar is included among the top collaborators of Anna Turkova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Turkova. Anna Turkova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tuberculosis disease among people with HIV: therapeutic advances 2025 ·The Lancet HIV ·Vidya Mave, Mandar Paradkar, Francesca Conradie, Amita Gupta, Anchalee Avihingsanon, Graeme Meintjes, Anna Turkova, Kelly E. Dooley, Richard E. Chaisson	0
2	Optimising Paediatric HIV Treatment: Recent Developments and Future Directions 2024 ·Pediatric Drugs ·(unknown), Alasdair Bamford, Alfredo Tagarro, Tim R. Cressey, (unknown), (unknown), Hilda Mujuru, Francis Atéba Ndongo, (unknown), Alexandra Compagnucci, Marc Lallemant, (unknown), Anna Turkova	3
3	Paediatric antiretroviral therapy challenges with emerging integrase resistance 2024 ·Current Opinion in HIV and AIDS ·Alasdair Bamford, Lisa Hamzah, Anna Turkova	5
4	Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe 2024 ·The Pediatric Infectious Disease Journal ·Farihah Malik, Siobhan Crichton, (unknown), (unknown), (unknown), Maria Pokorska‐Śpiewak, Marisa Navarro, Heather Bailey, Claire Thorne, Ali Judd, Anna Turkova, Intira Jeannie Collins	1
5	Emerging integrase resistance in an international perinatal virtual clinic 2024 ·AIDS ·(unknown), Nicola Mackie, (unknown), (unknown), Alasdair Bamford, Julia Kenny, Leon Levin, Hermione Lyall, (unknown), Katherine Simon, (unknown), Anna Turkova, Steven Welch, Caroline Foster	1
6	Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis 2023 ·PLoS Medicine ·(unknown), Roeland E. Wasmann, Chishala Chabala, Helena Rabie, Janice Lee, Irene Mukui, Anneke C. Hesseling, Heather J. Zar, Rob E. Aarnoutse, Anna Turkova, Diana M. Gibb, Mark F. Cotton, Helen McIlleron, Paolo Denti	4
7	The hard part we often forget: providing care to children and adolescents with advanced HIV disease 2023 ·Journal of the International AIDS Society ·Lisa Frigati, Diana M. Gibb, Joseph I. Harwell, (unknown), Victor Musiime, Helena Rabie, Ajay Rangaraj, Pablo Rojo, Anna Turkova, Martina Penazzato	4
8	Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance 2023 ·Viruses ·(unknown), Matthew Byott, Moira Spyer, Paul R. Grant, Kathleen Gärtner, (unknown), James O. Burton, Alasdair Bamford, Laura Waters, Carlo Giaquinto, Anna Turkova, Cindy Vavro, Eleni Nastouli	1
9	The Smooth Away From Expected (SAFE) non-inferiority frontier: theory and implementation with an application to the D3 trial 2023 ·Trials ·Matteo Quartagno, Man K. Chan, Anna Turkova, Deborah Ford, Ian R. White	0
10	Borrowing information across patient subgroups in clinical trials, with application to a paediatric trial 2022 ·BMC Medical Research Methodology ·Rebecca Turner, Anna Turkova, (unknown), Alasdair Bamford, Moherndran Archary, Linda Barlow‐Mosha, Mark F. Cotton, Tim R. Cressey, Elizabeth Kaudha, Abbas Lugemwa, Hermione Lyall, Hilda Mujuru, Veronica Mulenga, Victor Musiime, Pablo Rojo, Gareth Tudor‐Williams, Steven Welch, Diana M. Gibb, Deborah Ford, Ian R. White, (unknown)	5
11	Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial 2022 ·The Lancet HIV ·Hylke Waalewijn, Man K. Chan, (unknown), Hilda Mujuru, Shafic Makumbi, Adeodata Kekitiinwa, Elizabeth Kaudha, (unknown), Godfrey Musoro, (unknown), Abbas Lugemwa, Pauline Amuge, (unknown), Pablo Rojo, Carlo Giaquinto, Angela Colbers, Diana M. Gibb, Deborah Ford, Anna Turkova, David M. Burger	14
12	Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations 2021 ·Clinical Infectious Diseases ·Chishala Chabala, Anna Turkova, Anneke C. Hesseling, (unknown), (unknown), Monica Kapasa, Megan Palmer, Maxwell Chirehwa, Lubbe Wiesner, Eric Wobudeya, Aarti Kinikar, Vidya Mave, Syed Hissar, Louise Choo, (unknown), Veronica Mulenga, (unknown), Diana M. Gibb, Helen McIlleron	17
13	The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV 2020 ·Journal of the International AIDS Society ·Pablo Rojo, Deborah Carpenter, François Venter, Anna Turkova, Martina Penazzato	6
14	Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP) 2018 ·Trials ·James A. Seddon, Anthony J. Garcia‐Prats, (unknown), Muhammad Osman, Anne‐Marie Demers, Graeme Hoddinott, Angela M. Crook, (unknown), Margaret J. Thomason, Anna Turkova, Diana M. Gibb, Lee Fairlie, Neil Martinson, H. Simon Schaaf, Anneke C. Hesseling	45
15	Treating young children co-infected with tuberculosis and HIV 2018 ·The Lancet HIV ·Anna Turkova, Alasdair Bamford	2
16	Cancer in adolescents and young adults living with HIV 2018 ·Current Opinion in HIV and AIDS ·Julia Bohlius, Caroline Foster, Gita Naidu, Mazvita Sengayi, Anna Turkova	11
17	Long - term trends in mortality and AIDS-defining events among perinatally HIV-infected children across Europe and Thailand 2016 ·St George's Online Research Archive (St George's University of London) ·Ali Judd, (unknown), Katja Doerholt, (unknown), Carlo Giaquinto, Diana M. Gibb, Tessa Goetghebuer, Sophie Le Cœur, (unknown), Anna Turkova, Ruth Goodall	1
18	Survival of HIV-1 vertically infected children 2016 ·Current Opinion in HIV and AIDS ·Mary‐Ann Davies, Diana M. Gibb, Anna Turkova	46
19	Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy 2016 ·BMC Medicine ·(unknown), Angela M. Crook, Anna Turkova, Victor Musiime, Mutsa Bwakura‐Dangarembizi, Sabrina Bakeera–Kitaka, Patricia Nahirya-Ntege, Margaret J. Thomason, Peter Mugyenyi, Philippa Musoke, Adeodata Kekitiinwa, Paula Munderi, Kusum Nathoo, Andrew J. Prendergast, A. Sarah Walker, Diana M. Gibb	34
20	Prevalence, incidence, and associated risk factors of tuberculosis in children with HIV living in the UK and Ireland (CHIPS): a cohort study 2015 ·The Lancet HIV ·Anna Turkova, (unknown), Ali Judd, Ruth Goodall, Steven Welch, Caroline Foster, Andrew Riordan, Delane Shingadia, Fiona Shackley, Katja Doerholt, Diana M. Gibb, Intira Jeannie Collins	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact